BCLS Acquisition Corp.

BCLS Acquisition Corp. (Nasdaq: BLSA), sponsored by Bain Capital Life Sciences Investors, was a blank-check company targeting the healthcare and life sciences sector. The SPAC completed its initial public offering in 2020, raising capital to pursue a business combination within the biopharma and medical technology space. On November 7, 2022, the company filed a Form 15-12G with the SEC — accession number 0001193125-22-279137 — to suspend and terminate its reporting obligations under Section 12(g) of the Securities Exchange Act of 1934, marking the close of its public reporting lifecycle. Visit SpacDesk and sign up for full access to BLSA filings, timeline data, and sponsor history.